OPHELZI Trademark

Trademark Overview

On Tuesday, October 26, 2021, a trademark application was filed for OPHELZI with the United States Patent and Trademark Office. The USPTO has given the OPHELZI trademark a serial number of 97093042. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 16, 2024. This trademark is owned by Bausch + Lomb Ireland Limited. The OPHELZI trademark is filed in the Pharmaceutical Products category with the following description:

ophthalmic pharmaceutical substances and preparations for the treatment of ocular diseases and disorders
ophelzi

General Information

Serial Number97093042
Word MarkOPHELZI
Filing DateTuesday, October 26, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2022

Trademark Statements

Goods and Servicesophthalmic pharmaceutical substances and preparations for the treatment of ocular diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBausch + Lomb Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin 24
IE
Party NameBausch + Lomb Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin 24
IE

Trademark Events

Event DateEvent Description
Friday, October 29, 2021NEW APPLICATION ENTERED
Tuesday, November 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 18, 2022ASSIGNED TO EXAMINER
Wednesday, May 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 1, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 21, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 21, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 16, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 14, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, December 21, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, January 26, 2023SOU TEAS EXTENSION RECEIVED
Thursday, January 26, 2023SOU EXTENSION 1 FILED
Thursday, January 26, 2023SOU EXTENSION 1 GRANTED
Saturday, January 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 8, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 8, 2023SOU EXTENSION 2 FILED
Tuesday, August 8, 2023SOU EXTENSION 2 GRANTED
Thursday, August 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 16, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, January 17, 2024SOU EXTENSION 3 GRANTED
Wednesday, January 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 17, 2024SOU EXTENSION 3 FILED

Related Keywords

ophelzi ocular diseases disorders treatment preparations pharmaceutical substances ophthalmic